Depression Treatment in Normal Pressure Hydrocephalus
For older adults with normal pressure hydrocephalus (NPH) and depression, prioritize definitive NPH treatment with ventricular shunting first, as this addresses the underlying pathophysiology and may resolve depressive symptoms; if depression persists post-shunt or while awaiting surgery, use SSRIs (specifically sertraline, escitalopram, or citalopram) or mirtazapine, while strictly avoiding tricyclic antidepressants due to their risk of orthostatic hypotension and falls in this vulnerable population.
Understanding the NPH-Depression Connection
Depression is highly prevalent in NPH patients, affecting up to 71% of cases 1. The psychiatric symptoms often emerge before the classic triad becomes fully apparent, making diagnosis challenging 2, 3. Importantly, depression symptoms persist in approximately 46% of NPH patients even after shunt placement 4, indicating that while shunting helps, additional psychiatric intervention is frequently necessary.
Treatment Algorithm
Step 1: Evaluate for Shunt Candidacy First
- Screen for the NPH triad: gait disturbance, cognitive impairment, and urinary incontinence
- Obtain neuroimaging showing ventriculomegaly with characteristic features
- Perform CSF drainage testing (lumbar puncture or external lumbar drainage) to predict shunt responsiveness 5
- Shunt surgery should be prioritized as it addresses the root cause and produces sustained improvement in 80% of patients, with gait velocity improving by 54% at 8-12 months post-surgery 5
Step 2: Screen for Depression Systematically
Use a validated, brief screening tool appropriate for older adults 6:
- Geriatric Depression Scale-15 (GDS-15): scores ≥5 indicate suspected depression, ≥12 indicate severe depression 4
- Patient Health Questionnaire-9 (PHQ-9)
- Screen during initial evaluation and with any clinical decline 6
Step 3: Pharmacological Management of Depression
First-Line Antidepressants (Safe in Older Adults with NPH):
Mirtazapine (alpha-2 antagonist): 9, 7
- Safe alternative to SSRIs
- Can help with sleep and appetite
- Monitor for QT prolongation 9
Alternative options: Venlafaxine or vortioxetine 7
Medications to AVOID:
- Tricyclic antidepressants (TCAs): Absolutely contraindicated 9, 10
- Cause orthostatic hypotension—particularly dangerous in NPH patients already at high fall risk due to gait disturbance
- Can worsen cognitive function
- Risk of arrhythmias
Step 4: Non-Pharmacological Interventions
Implement alongside medication 9:
- Cognitive behavioral therapy (CBT): Shows promising results for depression in complex medical patients
- Structured exercise programs: When gait permits, aerobic exercise helps both depression and NPH symptoms 7
- Multidisciplinary team approach: Coordinate neurosurgery, psychiatry, and primary care
Step 5: Monitoring and Reassessment
- Evaluate treatment response within 6 weeks of initiating antidepressants 6, 11
- Identify and document specific target symptoms at baseline
- Reassess after shunt placement, as some depressive symptoms may resolve 4
- Continue antidepressants for at least 4 months for first episode 8
Critical Clinical Pitfalls
Fall Risk Management: NPH patients have baseline gait instability. Antidepressants that cause orthostatic hypotension (TCAs) or excessive sedation dramatically increase fall risk. SSRIs and mirtazapine have lower fall risk but still require monitoring 12.
Overlapping Symptoms: Psychomotor retardation in depression mimics NPH's cognitive slowing 3. Don't attribute all symptoms to depression—pursue NPH workup aggressively, as it's potentially reversible 2, 13.
Timing of Psychiatric Intervention: While awaiting neurosurgical evaluation or if surgery is delayed, initiate antidepressant therapy promptly. Depression worsens self-care, medication adherence, and functional outcomes 9.
Post-Shunt Depression Persistence: Nearly half of shunted NPH patients continue to have depressive symptoms 4. Screen for depression 3-4 months post-shunt and treat accordingly rather than assuming shunt surgery alone will resolve psychiatric symptoms.
Evidence Strength Considerations
The evidence base specifically for depression treatment in NPH is limited to case reports and observational studies 2, 3, 13, 1. However, the recommendations draw from:
- Strong evidence for antidepressant safety profiles in older adults with complex medical conditions 7, 8
- Clear contraindications for TCAs in conditions causing gait instability 9, 10
- Robust data on NPH shunt outcomes showing improvement in multiple domains including mood 5
The approach prioritizes morbidity and mortality by emphasizing fall prevention (avoiding TCAs), addressing reversible causes (shunting), and improving quality of life through comprehensive depression management.